Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Nucleus RadioPharma Secures Series A Extension

2024-06-05
ROCHESTER, MN, Nucleus RadioPharma announced the closing of a Series A extension round with new investor AstraZeneca.
Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the closing of a Series A extension round with new investor AstraZeneca. Concurrent with the financing, Tyrell Rivers, PhD, Executive Director of Corporate Ventures at AstraZeneca, was named to the Board of Directors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors